IAG Partners with BMC/BUSM
London, UK and Boston, MA - Image Analysis Group (IAG) announced today that they have partnered with a new CRO spun out by BMC/BUSM Radiology to provide life sciences, biotech, medical device and pharmaceutical clients with expert clinical research services in imaging.
This partnership will offer IAG’s proprietary cloud-based platform Dynamika for clinical trial data management, patented advanced image analysis algorithms for imaging data analysis, and renowned scientific and analytical expertise of the radiologists to conduct global clinical trials.
The partnership will allow for BMC/BUSM Radiology to market IAG’s industry leading cloud based software platform for clinical trial data management and image analysis DYNAMIKA while IAG’s’ clients will benefit from BMC/BUSM radiology and clinical services expertise in oncology, immune-oncology, neuro-oncology, neurology and inflammation. The new partners will work in tandem to provide trial and endpoint design, trial management, site selection and management, project management, technical expert and radiology services globally.
“We believe that the combination of the technology platform, algorithms and services and with BMC Radiology’s medical depth creates a clinical trial imaging management team unrivalled in the industry”, commended Dr. Olga Kubassova, CEO of Image Analysis Group.
“We are pleased to gain a partner with such complementary skills and look forward to working together,” added the president of Boston Radiology Associates, Dr. Jorge Soto.
About Image Analysis Group
Image Analysis Group is an expert clinical research organization, delivering systems, scientific expertise and full service to support efficient design and execution of clinical trials, where imaging provides critical evidence of the novel compound safety and efficacy.
About BMC/BUSM Radiology
Boston Medical Center Radiology is a group of academic radiologists with research expertise and extensive clinical trials experience in all specialties including oncology, neuro-oncology, trauma etc. Members of the department have recognized proficiency in clinical trials design, execution and management.
Empowering Sites and Patients: The Impact of Personalized Support in Clinical Trials
November 26th 2024To meet the growing demands of clinical research, sponsors must prioritize comprehensive support models, such as clinical site ambassadors and patient journey coordinators, who can address operational challenges and improve site relationships, patient satisfaction, and overall trial efficiency.
Driving Diversity with the Integrated Research Model
October 16th 2024Ashley Moultrie, CCRP, senior director, DEI & community engagement, Javara discusses current trends and challenges with achieving greater diversity in clinical trials, how integrated research organizations are bringing care directly to patients, and more.
FDA Finalizes Decentralized Clinical Trial Guidance
November 25th 2024The FDA's guidance is part of a broader effort to modernize clinical trials, improve efficiency, reduce participant burden, and expand access, particularly for underrepresented populations and those in geographically or economically constrained areas.
AI in Clinical Trials: A Long, But Promising Road Ahead
May 29th 2024Stephen Pyke, chief clinical data and digital officer, Parexel, discusses how AI can be used in clinical trials to streamline operational processes, the importance of collaboration and data sharing in advancing the use of technology, and more.
